|
⚲
|
| Keyboard |
| Georgiou George
✚
|
|
|---|---|
| CIK # | 0000749811 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0000749811] | |
| 4 | [0000749811] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Spyre Therapeutics Inc | |
| Georgiou George |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2018-08-13 | Option exercise | 17,333 | $7.28 | 126,184 |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2018-08-13 | Option exercise | 20,000 | $4.73 | 94,600 |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2018-08-13 | Option exercise | 20,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2018-08-13 | Option exercise | 17,333 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2018-06-07 | Grant | 18,400 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2017-12-01 | Grant | 30,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Director Stock Option (right to buy) · derivative
|
2016-05-17 | Grant | 24,000 | $0.00 |